InsidersTradesSigma
Strides Pharma Science Limited: directors' dealings · India · SEBI (PIT + SAST)
SEBI:strides-pharma-science-limitedIN·SEBI (PIT + SAST)Mcap 61.7Bn€
Explore the full directors' dealings record of Strides Pharma Science Limited, a listed equity based in India. Shares are quoted on IN IN, under the authority of SEBI (PIT + SAST). Market capitalisation: €61.7bn. The latest transaction was filed on 24 March 2022 (Purchase). Among the most active insiders: Pronomz Ventures LLP. The full history is free.
39
Insider Decl.
0
Thresholds
€4m
23 ops.
Buy Volume
€3m
16 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
1151.40 €
Income statement
Revenue43.92 Bn€
Gross profit22.58 Bn€51% margin
Net income35.93 Bn€81.8% margin
Balance sheet & cash
Market cap61.68 Bn€
Total debt18.80 Bn€
Free Cash Flow4.42 Bn€
Last declaration on 24 March 2022
Declarations39 total
Executives●Purchase0SEBI
€189,33545,450 shares@ €4.1658
Equity Shares
SEBI:7b44e46e6ee249555dcb3809f062f27209ef52b0·
Ideal exit: 16 Dec 2022 (T+270)
Executives●Purchase0SEBI
€209,70653,200 shares@ €3.9418
Equity Shares
SEBI:6c93527891d2065eb9a74c359c908a92c9ff60fa·
Ideal exit: 11 Dec 2022 (T+270)
Executives●Purchase0SEBI
€1m300,000 shares@ €3.8704
Equity Shares
SEBI:69c86e43d509cb7ad07af91fa9ff3f831b7d1cc8·
Ideal exit: 9 Dec 2022 (T+270)
Executives●Purchase0SEBI
€1m291,250 shares@ €3.8123
Equity Shares
SEBI:286771d5076760fe149bb2111c0338152f22f1eb·
Ideal exit: 29 Nov 2022 (T+270)
Executives●Purchase0SEBI
€194,09652,000 shares@ €3.7326
Equity Shares
SEBI:0af2be3627c09e7fa760032f7f9ebe920aca4bf3·
Ideal exit: 25 Nov 2022 (T+270)
Executives●Purchase0SEBI
€6,0061,550 shares@ €3.875
Equity Shares
SEBI:bc3c6e68d87cb728c3dc5735166c79e88641781d·
Ideal exit: 21 Nov 2022 (T+270)
Executives●Purchase0SEBI
€590,897155,200 shares@ €3.8073
Equity Shares
SEBI:886558ffe2f68a95a80a67b294fae2d78d3a58ad·
Ideal exit: 21 Nov 2022 (T+270)
Executives●Sale0SEBI
€19,0492,600 shares@ €7.3265
Equity Shares
SEBI:da4da765acbf12a1efc02a7bcbec8077fe37f9e2·
Executives●Sale0SEBI
€29,1064,000 shares@ €7.2764
Equity Shares
SEBI:bb89d6aeb99a1b397593d54f772b4b40a519282f·
Executives●Sale0SEBI
€17,4162,500 shares@ €6.9662
Equity Shares
SEBI:d336305a1693c2b445e9a62f1997ae6e7478c30e·
Executives●Purchase0SEBI
€13,7234,000 shares@ €3.4308
Equity Shares
SEBI:41a366a4c8db04da99e25821bfdf6d7a7c2a2bea·
Ideal exit: 3 May 2022 (T+270)
Executives●Purchase11SEBI
€12,9983,750 shares@ €3.4660.0000% mcap100.0% of flow
Equity Shares
SEBI:e8d76ac4b9005e038030bd8ecc4c171196962632·
Ideal exit: 3 Jun 2022 (T+270)
Executives●Purchase7SEBI
€12,9983,750 shares@ €3.4660.0000% mcap39.7% of flow
Equity Shares
SEBI:4f308a55bcecd1ca822cd6ad07991f38855c0941·
Ideal exit: 3 Jun 2022 (T+270)
Executives●Purchase6SEBI
€12,9983,750 shares@ €3.4660.0000% mcap28.8% of flow
Equity Shares
SEBI:43a75685095cb6fe8f5dc243b3c1243dacf97450·
Ideal exit: 3 Jun 2022 (T+270)
Executives●Purchase11SEBI
€12,9983,750 shares@ €3.4660.0000% mcap100.0% of flow
Equity Shares
SEBI:1478c8e242cf09836975e6560cf2d406f5026753·
Ideal exit: 3 Jun 2022 (T+270)
Executives●Purchase11SEBI
€13,8644,000 shares@ €3.4660.0000% mcap100.0% of flow
Equity Shares
SEBI:05255a66d070fc71fce0544ea378e9c1ee91e8b4·
Ideal exit: 3 Jun 2022 (T+270)
Executives●Sale11SEBI
€160,61920,000 shares@ €8.0310.0003% mcap100.0% of flow
Equity Shares
SEBI:36d17328b8f0f6e50fe1f3a41bd8c1310388bb52·
Executives●Sale11SEBI
€21,4112,500 shares@ €8.56430.0000% mcap100.0% of flow
Equity Shares
SEBI:449285e23e3f0b296482651a7b09c85585bbf6e7·
Executives●Sale10SEBI
€32,1773,750 shares@ €8.58060.0001% mcap71.2% of flow
Equity Shares
SEBI:c44a5a569cc57282acbe3344cbfadbeb8b3ef8ba·
Executives●Purchase8SEBI
€61,11420,000 shares@ €3.05570.0001% mcap49.8% of flow
Equity Shares
SEBI:8a4f4b71affa6d0c9a21cfeb56e0d360739d7fa8·
Ideal exit: 27 Mar 2022 (T+270)
Executives●Sale9SEBI
€19,7442,280 shares@ €8.65950.0000% mcap60.3% of flow
Equity Shares
SEBI:12bfeb5a913c22334278a88627fcd141a41ec583·
Executives●Purchase3SEBI
057,869 shares
Equity Shares
SEBI:626d1ecea5c5e7ca5c5ec4be6c7b466347d0e70e·
Ideal exit: 21 Mar 2022 (T+270)
Executives●Sale3SEBI
088,734 shares
Equity Shares
SEBI:e2bf6e4ac4065df6c1c8fc0b1f112f91019d1ec6·
25 of 39 declarations